Venture&Growth
Location
Barcelona, Spain 
Venture&Growth
All Portfolio items
See full Venture&Growth portfolio
Splice Bio is a biotech company based on intein technologies developed in the Muir Lab at Princeton University. They are working with their proprietary platform to address key limitations of current gene therapy approaches to treat patients in need. The company is building a product pipeline of gene therapies targeting inherited retinal diseases and other severe genetic diseases for which there is no cure.
More Splice Bio news
Gilde Healthcare invests in Eur 50M series A round of Spanish Gene Therapy company SpliceBio
Eargo
US-based MedTech company selling hearing aid solutions to patients suffering from hearing loss.
Axonics Modulation Technologies
US MedTech company focused on neuromodulation.
Noema Pharma
Swiss Therapeutics company developing therapies to treat severe neurological disorders.
